Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of MT-304 in Adults With Advanced HER2-Expressing Solid Tumors
Myeloid Therapeutics
Myeloid Therapeutics
Incyte Corporation
Novartis
MacroGenics
Nurix Therapeutics, Inc.
Bicara Therapeutics
Xencor, Inc.
Toray Industries, Inc
Context Therapeutics Inc.
Exelixis
Carisma Therapeutics Inc
Nerviano Medical Sciences
Hoffmann-La Roche
University Hospital, Geneva
Eli Lilly and Company
BioEclipse Therapeutics
Xencor, Inc.
MacroGenics
Karolinska University Hospital
AIDS Malignancy Consortium
Abramson Cancer Center at Penn Medicine
Pfizer
Alliance for Clinical Trials in Oncology
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
University of Arizona
City of Hope Medical Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
SWOG Cancer Research Network
University of California, San Francisco
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Dartmouth-Hitchcock Medical Center
University of Alabama at Birmingham
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Duke University
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Cancer Research UK
Rutgers, The State University of New Jersey
National Cancer Institute (NCI)
NYU Langone Health